Noramco, a global API manufacturer specializing in controlled substances, launched the Noramco Group, a comprehensive North American-based supply chain solution including subsidiaries Purisys, Noramco, and the newly acquired drug product CDMO, Halo Pharma. This strategic combination aims to provide a robust, domestic supply chain solution for both clinical and commercial APIs and drug products.   The formation of the Noramco Group aims to help address drug shortages in the U.S. and quality con...